Posted by UBC on May 21, 2013
U.S. spending on specialty prescription drugs is projected to increase 67 percent by the end of 2015, according to the Drug Trend Report and forecast released today by Express Scripts.
Prescription drug spending on eight of the top 10 specialty therapy classes will continue to increase... read more.
Posted by UBC on May 15, 2013
UBC scientists never stop learning. And, they never stop sharing what they’ve learned. As healthcare professionals committed to improving patient outcomes, our scientists often use their research and studies for teaching opportunities.
Congratulations to three of our... read more.
Posted by UBC on May 9, 2013
One week isn’t nearly enough time to recognize everything nurses do for us. Let’s face it – nurses save lives. Day in, day out, they provide care and education, administer medication, and evaluate patients’ symptoms. In addition, they hold hands, calm... read more.
Posted by Krista Payne, Executive Director, Sr. Research Scientist, Peri & Postapproval Services on May 7, 2013
Traditionally, chart review studies have been employed to evaluate burden of illness and patterns of care, but, increasingly, this methodology is being applied to meet marketing authorization and risk management data requirements including data that reflect patterns of off label medication use.... read more.
Posted by UBC on May 3, 2013
Traditional prescription adherence measures have been around for two to three decades. These programs’ ability to drive patient compliance are well understood – both in their effectiveness and their limitations.
Cost reduction programs such as a copay waiver or a copay card;... read more.
Posted by UBC on April 29, 2013
When developing a European Risk Minimization program, one size really doesn’t fit all. Manufacturers must consider that healthcare practices vary across Europe, leading to challenges in the implementation of risk minimization measures and effectiveness evaluation.
But that... read more.
Posted by UBC on April 26, 2013
ISPOR, the International Society for Pharmacoeconomics and Outcomes Research, is recognized globally as the authority for health economics and outcomes research and its use in healthcare decisions towards improved health.
UBC Value Demonstration scientists have played an... read more.
Posted by Jennifer Allen, Sr. Program Manager on April 25, 2013
In the age of modernized medicine, patients were primarily limited to two sites of care: the physician’s office or the hospital. However, since 1965 when Medicare first included home health nursing as a benefit, nurses provide care in patients’ homes as well as in a variety of other... read more.
Posted by UBC on April 24, 2013
PopSci’s recent blog posting describes for a larger audience what our manufacturer clients already know: how a drug gets its name. It’s no news to you that a drug has at least three names, including chemical, commercial, and generic. And, it’s certainly no surprise... read more.
Posted by Sallyanne Williams, Executive Director, North American Operations on April 18, 2013
In just a few short days, UBC will be meeting with manufacturer sponsors at Partnerships in Clinical Trials 2013. We look forward to collaborating with you and sharing insights we’ve learned through successfully developing, implementing, and supporting many of the industry’s... read more.